GeneOne Life Science, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was KRW 149.88 million compared to KRW 184.78 million a year ago. Net loss was KRW 4,621.83 million compared to KRW 1,829.95 million a year ago.

Basic loss per share from continuing operations was KRW 60 compared to KRW 27.3333 a year ago. Diluted loss per share from continuing operations was KRW 60 compared to KRW 27.3333 a year ago. Basic loss per share was KRW 60 compared to KRW 41 a year ago.